Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of rTMS Over the Medial Cerebellum on Negative Symptoms and Cognitive Dysmetria in Subjects With Treatment Refractory Schizophrenia

NCT02242578 is registered in ClinicalTrials.gov with Seton Healthcare Family as lead sponsor.

NCT NCT02242578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02242578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of rTMS Over the Medial Cerebellum on Negative Symptoms and Cognitive Dysmetria in Subjects With Treatment Refractory Schizophrenia
Lead sponsor
Seton Healthcare Family
Phase
Not applicable
Overall status
Terminated
Start date
January 24, 2011
Completion date
June 11, 2018
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia